PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy

We retrospectively analyzed PDL1 mRNA expression in 306 breast cancer samples, including 112 samples of an aggressive form, inflammatory breast cancer (IBC). PDL1 expression was heterogeneous, but was higher in IBC than in non-IBC. Compared to normal breast samples, PDL1 was overexpressed in 38% of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertucci, François, Finetti, Pascal, Colpaert, Cécile, Mamessier, Emilie, Parizel, Maxime, Dirix, Luc, Viens, Patrice, Birnbaum, Daniel, van Laere, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537030/
https://www.ncbi.nlm.nih.gov/pubmed/25940795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537030/
https://www.ncbi.nlm.nih.gov/pubmed/25940795

Ejemplares similares